Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim.
Couzin
Jennifer
J
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000235:genetics*; D000077156:Gefitinib; D005820:Genetic Testing; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D010597:Pharmacogenetics / Q000379:methods*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib